World Thyroid Day: Unleashing the Power of Thyroid Health with Genomic Testing

Every year on May 25th, World Thyroid Day raises awareness about thyroid disorders — conditions that affect an estimated 42 million people in India alone, making thyroid disease one of the most prevalent endocrine conditions in the country. Despite this prevalence, thyroid disorders remain significantly underdiagnosed and undertreated. Genomic testing is opening new frontiers in understanding thyroid health — from inherited risk to personalized treatment.

Understanding the Thyroid Gland

The thyroid gland — a butterfly-shaped gland at the base of the neck — produces thyroid hormones (T3 and T4) that regulate metabolism, energy production, heart rate, body temperature, and virtually every organ system in the body. When the thyroid produces too much hormone (hyperthyroidism) or too little (hypothyroidism), the effects are wide-ranging and can significantly impact quality of life.

Common Thyroid Disorders

Hypothyroidism

The most common thyroid disorder in India. The thyroid produces insufficient hormone, causing fatigue, weight gain, cold intolerance, constipation, dry skin, hair loss, depression, and cognitive slowing. The most common cause is Hashimoto's thyroiditis — an autoimmune condition in which the immune system attacks the thyroid gland.

Hyperthyroidism

The thyroid produces excess hormone, causing weight loss, rapid heartbeat, heat intolerance, anxiety, tremor, and increased sweating. The most common cause is Graves' disease — another autoimmune condition.

Thyroid Nodules and Goiter

Thyroid nodules are extremely common — found in up to 50% of adults on ultrasound. Most are benign, but approximately 5–10% are malignant. Goiter (thyroid enlargement) can result from iodine deficiency, autoimmune disease, or nodular growth.

Thyroid Cancer

The most common endocrine malignancy. Papillary thyroid cancer accounts for approximately 80% of cases and has an excellent prognosis with appropriate treatment. Medullary thyroid cancer has a significant hereditary component (approximately 25% of cases are caused by RET gene mutations).

The Genetics of Thyroid Disease

Thyroid disorders have significant genetic components. Hashimoto's thyroiditis and Graves' disease are associated with HLA gene variants and other immune regulation genes (PTPN22, CTLA4). Family history is a strong risk factor for autoimmune thyroid disease. For medullary thyroid cancer, RET gene mutations cause hereditary disease — and genetic testing with cascade family testing is standard of care.

Genetic variants also affect thyroid hormone metabolism. Variants in DIO2 (deiodinase 2) affect the conversion of T4 to the active T3 hormone — and may explain why some patients feel better on combination T4/T3 therapy rather than T4 alone.

Genomic Testing and Thyroid Health

• Inherited risk assessment: Identify genetic predisposition to autoimmune thyroid disease and thyroid cancer
• Thyroid nodule evaluation: Molecular testing of thyroid nodule biopsies (Afirma, ThyroSeq) helps determine malignancy risk and guide surgical decisions
• Medullary thyroid cancer: RET germline testing for all MTC patients and cascade family testing
• Treatment optimization: DIO2 variants may guide T4 vs. T4/T3 combination therapy decisions

FAQs

Should I get genetic testing if I have thyroid disease?

Genetic testing is most clearly indicated for medullary thyroid cancer (RET testing) and for families with multiple members affected by thyroid disease. For autoimmune thyroid disease, genetic testing can identify inherited risk but doesn't change management. Discuss with your endocrinologist whether testing is appropriate for your situation.

Is thyroid disease more common in women?

Yes. Autoimmune thyroid disease is 5–10× more common in women than men, likely due to hormonal and immune system differences. However, thyroid disease in men is often more severe when it does occur, partly because it's diagnosed later.